2 unknown, 1 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow 9MW3811 Injection: new trials by email Literature Review of 9MW3811 Injection trials Research Report on 9MW3811 Injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of 9MW3811 in Patients With Pathological Scar 9MW3811 Injection, Placebo - Scar | Phase 2 | Recruiting | Mabwell (Shanghai) Bioscience Co., Ltd. | 30 | 2025-12-29 | 2026-05-08 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects 9MW3811 Injection, Placebo - Idiopathic Pulmonary Fibrosis | Phase 1 | Unknown | Mabwell (Shanghai) Bioscience Co., Ltd. | 24 | 2023-07-26 | 2023-09-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Preliminary Efficacy of 9MW3811 in Patients With Advanced Solid Tumors 9MW3811 Injection - Advanced Malignant Solid Tumor | Phase 1 | Unknown | Mabwell (Shanghai) Bioscience Co., Ltd. | 27 | 2023-06-30 | 2023-06-22 |
| A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects 9MW3811 injection, Placebo - Pulmonary Fibrosis, Tumor | Phase 1 | Completed | Mabwell (Shanghai) Bioscience Co., Ltd. | 32 | 2023-03-20 | 2025-12-09 |
Cicatrix (1) · Idiopathic Pulmonary Fibrosis (1) · Neoplasms (1) · Pulmonary Fibrosis (1)
Mabwell (Shanghai) Bioscience Co., Ltd. (4)
China (3) · Australia (1)